Patents by Inventor Martin J. Fennell

Martin J. Fennell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240023848
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned analyte sensor automatically or on demand upon request from a user.
    Type: Application
    Filed: February 17, 2023
    Publication date: January 25, 2024
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Publication number: 20230346269
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: June 23, 2023
    Publication date: November 2, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Publication number: 20230273071
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Application
    Filed: March 10, 2023
    Publication date: August 31, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Saeed NEKOOMARAM, Martin J. FENNELL, Mark Kent SLOAN, Lei HE, Jeffery Mario SICURELLO
  • Patent number: 11737687
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: August 29, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, Martin J. Fennell, Daniel M. Bernstein
  • Publication number: 20230268071
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 24, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20230238131
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: April 3, 2023
    Publication date: July 27, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20230233112
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Application
    Filed: April 4, 2023
    Publication date: July 27, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
  • Patent number: 11696684
    Abstract: Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver is configured for communicating with a remote transmitter unit coupled with a glucose sensor. The glucose sensor generates data signals associated with a glucose level. The receiver unit includes a processor, a display, and a memory for storing instructions which, when executed by the processor: access a transmitter key associated with the remote transmitter unit; transmit a command to the remote transmitter unit after verifying the transmitter key; receive communication packets from the remote transmitter unit including a first data segment with data signals indicative of the glucose level and a second data segment with information corresponding to a remaining life of the remote transmitter unit; estimate a remaining life of the remote transmitter unit; process the data signals; and output the estimated remaining life and the processed data signals for display.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: July 11, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20230165466
    Abstract: Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver unit is configured to receive a key associated with a transmitter unit that enables the receiver unit to identify the transmitter unit, initiate communication with the transmitter unit, access a communication key uniquely associated with the transmitter unit, and receive communication packets from the remote transmitter unit on a periodic basis including data indicative of a glucose level of a bodily fluid. The receiver unit is further configured to process the data determine the glucose level for display, output a numerical representation of the determined glucose level in a GUI, and transmit data indicative of the glucose level to a second receiver unit.
    Type: Application
    Filed: January 13, 2023
    Publication date: June 1, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20230143496
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: January 10, 2023
    Publication date: May 11, 2023
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Patent number: 11635332
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: April 25, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Patent number: 11571147
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: February 7, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Publication number: 20220361756
    Abstract: Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver is configured for communicating with a remote transmitter unit coupled with a glucose sensor. The glucose sensor generates data signals associated with a glucose level. The receiver unit includes a processor, a display, and a memory for storing instructions which, when executed by the processor: access a transmitter key associated with the remote transmitter unit; transmit a command to the remote transmitter unit after verifying the transmitter key; receive communication packets from the remote transmitter unit including a first data segment with data signals indicative of the glucose level and a second data segment with information corresponding to a remaining life of the remote transmitter unit; estimate a remaining life of the remote transmitter unit; process the data signals; and output the estimated remaining life and the processed data signals for display.
    Type: Application
    Filed: July 27, 2022
    Publication date: November 17, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20220359074
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20220330856
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Application
    Filed: November 22, 2021
    Publication date: October 20, 2022
    Inventors: Martin J. Fennell, Jean-Pierre Cole, Theodore John Kunich, Udo Hoss, Benjamin Jay Feldman, Zenghe Liu
  • Publication number: 20220283042
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Application
    Filed: October 19, 2021
    Publication date: September 8, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Patent number: D955599
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: June 21, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D957642
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D957643
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D962446
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: August 30, 2022
    Assignee: ABBOTT DIABETES CARE, INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub